About Us
We Are Imageners.
We believe that our Oncology Intelligence unlocks powerful, previously unattainable insights that drive new discoveries. We turn cancer data into intelligence that can help today’s patients and accelerate tomorrow’s therapies.
Leadership
Dean Bitan
CEO & Co-founder
Jonathan Zalach
CDSO & Co-founder
Shahar Porat
CTO & Co-founder
Inbal Gazy, PhD
VP of Science & Regulatory Strategy
Michael Hreczuck
SPV of Business Development
Brian Laffin, PhD
Head of Translational & Clinical Strategy
Kimberly Collins, PhD
VP of Product Marketing
Joining very soon, MD
VP of Pathology
Our multidisciplinary team includes scientists, AI experts, physicians, and technology professionals who push boundaries in a can-do environment. We are mission-driven; we welcome challenges and pursue innovation and above all, we are committed to a patient-first mindset.
Our multidisciplinary team includes scientists, AI experts, physicians, and technology professionals who push boundaries in a can-do environment. We are mission-driven; we welcome challenges and pursue innovation and above all, we are committed to a patient-first mindset.
Investors & Board of Directors
Larry Ellison Chairman & CTO Oracle
David Agus, MD
Founding CEO
Ellison Medical Institute
Yodfat Harel Buchris Managing Director Blumberg Capital
David J. Blumberg
Founder & Managing Partner, Blumberg Capital
Eyal Gura Entrepreneur & Venture Investor